市場調査レポート

商品コード

1563385

インスリンポンプの市場規模、シェア、成長分析、製品タイプ別、付属品別、最終用途別、地域別 - 産業予測、2024年～2031年

Insulin Pump Market Size, Share, Growth Analysis, By Type, By Product, By Accessories, By End Use, By Region - Industry Forecast 2024-2031

出版日: 2024年09月28日
発行: SkyQuest
ページ情報: 英文 165 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 779,047円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 911,338円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,043,629円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
目次

概要

サンプル依頼リストに入れる

インスリンポンプの世界市場規模は、2022年に55億9,000万米ドルと評価され、2023年の60億5,000万米ドルから2031年には113億8,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは8.22％で成長する見通しです。

インスリンポンプ市場は、主に世界規模での糖尿病、特に1型糖尿病の有病率の上昇に牽引され、大きな成長を遂げています。2019年の糖尿病患者数は5億3,700万人と推定され、2045年には7億8,300万人に達すると予測されています。大手医療機器メーカーは、人工知能（AI）や機械学習（ML）などの機能を統合した洗練されたインスリンポンプを革新し、リリースしているため、この急増は技術の進歩によって補完されています。こうした開発は、ユーザーエクスペリエンスを向上させるだけでなく、治療効果も改善させる。糖尿病管理および治療の選択肢に対する認識が拡大し、ヘルスケアコストの高騰や医療機関へのアクセスの改善と相まって、インスリンポンプ市場は急成長を遂げる位置にあります。さらに、米国の市場情勢を反映し、今後数年間は堅調なCAGRを維持すると予想されています。このような技術革新とヘルスケア需要の高まりの組み合わせは、インスリンポンプ市場の有望な可能性を強調し、糖尿病ケアソリューションへの投資と市場開拓の焦点となっています。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Medtronic（Ireland）
Hoffmann-La Roche AG（Switzerland）
Tandem Diabetes Care, Inc.（US）
Insulet Corporation（US）
Ypsomed AG（Switzerland）
Sanofi S.A.（France）
Sooil Development（Korea）
Jiangsu Delfu Co., Ltd.（China）
Cellnovo Ltd.（UK）
Valeritas, Inc.（US）
Debiotech S.A.（Switzerland）
CeQur Simplicity（Switzerland）
Microtec Medical Ltd.（UK）
ViCentra B.V.（Netherlands）
EOFLOW CO., LTD.（Korea）
Becton, Dickinson and Company（US）
Abbott Laboratories（US）
Braun Melsungen AG（Germany）
Animus Corporation（US）
Asante（US）
Nipro Diagnostic, Inc.（Japan）

Product Code: SQMIG35A2135

Global Insulin Pump Market size was valued at USD 5.59 billion in 2022 and is poised to grow from USD 6.05 billion in 2023 to USD 11.38 billion by 2031, growing at a CAGR of 8.22 % in the forecast period (2024-2031).

The insulin pump market is experiencing significant growth, driven primarily by the rising prevalence of diabetes, especially type 1 diabetes, on a global scale. With an estimated 537 million individuals living with diabetes in 2019-a figure projected to reach 783 million by 2045-there is an increasing demand for portable insulin delivery systems among patients. This surge is complemented by advancements in technology, as leading medical device manufacturers innovate and release sophisticated insulin pumps integrated with features like artificial intelligence (AI) and machine learning (ML). These developments not only enhance user experience but also improve treatment efficacy. As awareness of diabetes management and treatment options expands, coupled with the escalation in healthcare costs and improved access to medical facilities, the market for insulin pumps is positioned for rapid growth. Furthermore, the U.S. insulin pump market is expected to sustain a robust compound annual growth rate (CAGR) in the upcoming years, reflecting a healthy market landscape. This combination of technological innovation and increasing healthcare demands underscores the insulin pump market's promising potential, making it a focal point for investment and development in diabetes care solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Insulin Pump market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Insulin Pump Market Segmental Analysis

Global Insulin Pump Market is segmented on the basis of type, product, accessories, end use, and region. By type, market is segmented into patch pumps, and tethered pumps. By product, market is segmented into MiniMed, Accu-Chek, Tandem, Omnipod, and others. By accessories, market is segmented into insulin reservoir or cartridges, insulin set insertion devices, and battery. By End use, market is segmented into hospitals & clinics, homecare, and laboratories. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the Global Insulin Pump Market

The growing adoption of insulin pumps among diabetic patients, both in developed and emerging markets, serves as a significant driver for the global insulin pump market. Market participants are increasingly focusing their research and development efforts on innovative, technologically advanced products to meet this rising demand. The positive outcomes from various clinical trials highlighting improved glucose control in type 2 diabetes patients utilizing pump therapy versus those on Multiple Daily Injection (MDI) therapy further boost market prospects. As patients and healthcare providers seek superior diabetes management solutions, the continuous advancement and introduction of new insulin delivery devices will enhance market growth, fostering improved patient outcomes.

Restraints in the Global Insulin Pump Market

The Global Insulin Pump market faces significant restraints primarily due to limited reimbursement options and the high costs associated with insulin pumps, making them less accessible for patients who heavily rely on financial support for treatment. This is particularly pronounced in underdeveloped and emerging countries, where awareness of diabetes and insulin pump technologies is low, stemming from inadequate healthcare infrastructure. The International Diabetes Federation reported that approximately 232 million diabetics were undiagnosed in 2019, further complicating market penetration. As a result, these financial and awareness barriers hinder the widespread adoption of insulin pump technologies, potentially stalling market growth.

Market Trends of the Global Insulin Pump Market

The Global Insulin Pump market is poised for significant growth, driven by the integration of intelligent technologies such as AI into healthcare IT. This advancement facilitates the development of AI-enabled insulin pumps and automated drug delivery systems, particularly tailored for type 2 diabetes management. As the prevalence of type 2 diabetes continues to rise, there is an increasing demand for technologically advanced insulin pumps, with current adoption rates hovering around 5% and projected to reach approximately 15% by 2027. This shift reflects a broader trend towards innovation in diabetes care, positioning the insulin pump market for robust expansion in the coming years.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
PESTEL Analysis
Technology Analysis
Pricing Analysis
Supply Chain Analysis

Insulin Pump Market, By Type

Market Overview
Patch pumps
Tethered pumps

Insulin Pump Market, By Product

Market Overview
MiniMed
Accu-Chek
Tandem
Omnipod
Others

Insulin Pump Market, By Accessories

Market Overview
Insulin reservoir or cartridges
Insulin set insertion devices
Battery

Insulin Pump Market, By End Use

Market Overview
Hospitals & clinics
Homecare
Laboratories

Insulin Pump Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tandem Diabetes Care, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Insulet Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ypsomed AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sooil Development (Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jiangsu Delfu Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cellnovo Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Valeritas, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Debiotech S.A. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CeQur Simplicity (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Microtec Medical Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ViCentra B.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EOFLOW CO., LTD. (Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Animus Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Asante (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nipro Diagnostic, Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

インスリンポンプの市場規模、シェア、成長分析、製品タイプ別、付属品別、最終用途別、地域別 - 産業予測、2024年～2031年

Insulin Pump Market Size, Share, Growth Analysis, By Type, By Product, By Accessories, By End Use, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

インスリンポンプ市場：タイプ別

インスリンポンプ市場：製品別

インスリンポンプ市場：アクセサリー別

インスリンポンプ市場：最終用途別

インスリンポンプ市場規模：地域別